[Role of prostaglandins and the beta-adrenergic system in central and peripheral hyperkinesia in borderline hypertension]. 1991

J L Megnien, and J Levenson, and A Simon
Centre de Médecine Préventive Cardio-Vasculaire, Hôpital Broussais, Paris.

The effects of short-term administration of indomethacin and propranolol were studied in two groups of patients with borderline hypertension and both central and peripheral hyperkinesia. Indomethacin and propranolol both significantly increased total peripheral resistance (respectively +32 +/- 3%, +59 +/- 7%, p less than 0.001). The increase in blood pressure after administrating propranolol was not significant (+3 +/- 2%), as opposed to what was obtained with indomethacin, (+5 +/- 2%, p less than 0.02). On the brachial artery, Indomethacin had no effect on blood flow and local resistance, on the other hand propranolol induced a decrease in blood flow in the brachial artery (-43 +/- 3%, p less than 0.001) and an elevation of local resistance (+105 +/- 18%, p less than 0.01). While central hyperkinesia depends on both prostaglandins and on the beta-adrenergic system, high muscle blood flow seems to be regulated by the beta-adrenergic system alone, without participation of prostaglandins.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007213 Indomethacin A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES. Amuno,Indocid,Indocin,Indomet 140,Indometacin,Indomethacin Hydrochloride,Metindol,Osmosin
D008297 Male Males
D011433 Propranolol A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs. Dexpropranolol,AY-20694,Anaprilin,Anapriline,Avlocardyl,Betadren,Dociton,Inderal,Obsidan,Obzidan,Propanolol,Propranolol Hydrochloride,Rexigen,AY 20694,AY20694,Hydrochloride, Propranolol
D011453 Prostaglandins A group of compounds derived from unsaturated 20-carbon fatty acids, primarily arachidonic acid, via the cyclooxygenase pathway. They are extremely potent mediators of a diverse group of physiological processes. Prostaglandin,Prostanoid,Prostanoids
D011943 Receptors, Adrenergic, beta One of two major pharmacologically defined classes of adrenergic receptors. The beta adrenergic receptors play an important role in regulating CARDIAC MUSCLE contraction, SMOOTH MUSCLE relaxation, and GLYCOGENOLYSIS. Adrenergic beta-Receptor,Adrenergic beta-Receptors,Receptors, beta-Adrenergic,beta Adrenergic Receptor,beta-Adrenergic Receptor,beta-Adrenergic Receptors,Receptor, Adrenergic, beta,Adrenergic Receptor, beta,Adrenergic beta Receptor,Adrenergic beta Receptors,Receptor, beta Adrenergic,Receptor, beta-Adrenergic,Receptors, beta Adrenergic,beta Adrenergic Receptors,beta-Receptor, Adrenergic,beta-Receptors, Adrenergic
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006948 Hyperkinesis Excessive movement of muscles of the body as a whole, which may be associated with organic or psychological disorders. Hyperactivity, Motor,Hyperkinesia,Hyperkinesia, Generalized,Hyperkinetic Movements,Generalized Hyperkinesia,Generalized Hyperkinesias,Hyperkinesias, Generalized,Hyperkinetic Movement,Motor Hyperactivity,Movement, Hyperkinetic,Movements, Hyperkinetic

Related Publications

J L Megnien, and J Levenson, and A Simon
December 1992, Angiology,
J L Megnien, and J Levenson, and A Simon
January 2001, Clinical and experimental hypertension (New York, N.Y. : 1993),
J L Megnien, and J Levenson, and A Simon
October 1984, Nihon Naibunpi Gakkai zasshi,
J L Megnien, and J Levenson, and A Simon
October 1973, European journal of clinical pharmacology,
J L Megnien, and J Levenson, and A Simon
January 1979, Archivos del Instituto de Cardiologia de Mexico,
J L Megnien, and J Levenson, and A Simon
June 1981, Archives des maladies du coeur et des vaisseaux,
J L Megnien, and J Levenson, and A Simon
January 1986, Terapevticheskii arkhiv,
J L Megnien, and J Levenson, and A Simon
January 1979, Annual review of physiology,
J L Megnien, and J Levenson, and A Simon
December 1989, Journal of hypertension. Supplement : official journal of the International Society of Hypertension,
J L Megnien, and J Levenson, and A Simon
April 1973, British heart journal,
Copied contents to your clipboard!